
Commentary|Podcasts|May 29, 2024
AI in Clinical Trials: A Long, But Promising Road Ahead
Author(s)Miranda Schmalfuhs
Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Stephen Pyke, chief clinical data and digital officer, Parexel discusses:
- A broad overview of the use of artificial intelligence in clinical development and how regulatory bodies are viewing it
- How AI can be used in clinical trials to streamline operational processes
- The importance of collaboration and data sharing in advancing the use of technology, and more
- The importance of considering the experience of patients when integrating artificial intelligence as well as some of the benefits they will see from it
- Human oversight when using artificial intelligence to aid in decision making
Trending on Applied Clinical Trials Online
1
ICON Selects Microsoft as Preferred Technology Partner to Scale Agentic AI Platform Across Clinical Trial Lifecycle
2
ACT Brief: Mixed FSP Strategy, DIA Meeting Trends, and Patient Voice in Oncology
3
ACT Brief: Real-Time Evidence Generation, Protocol Digitization, and Decentralized Trial Flexibility
4
ACT Brief: ICON-Microsoft AI Partnership, DCT Site Burden, and AI-Enabled Neuroimmune Discovery
5
